Gastric Cancer Foundation Gastric Cancer Foundation | Hope in Research

ALX Oncology’s ALX148 Receives Two Fast Track Designations from FDA for the Treatment of Patients with Head and Neck Squamous Cell Carcinoma and Patients with Gastric or Gastroesophageal Junction Adenocarcinoma

Mar 27 2020

ALX Oncology won fast-track designation from the FDA for its drug ALX148 in the second-line treatment of patients with HER2-positive...
Read More
Family History of Gastric Cancer and Helicobacter pylori Treatment

Mar 25 2020

A new study in the New England Journal of Medicine concludes that eradicating H. Pylori in people with a family...
Read More
Manish Shah, MD, discusses avelumab’s effectiveness based on results from the JAVELIN 100 study

Mar 12 2020

Manish Shah of Weill Cornell Medicine explains the results of a recent study in which gastric cancer patients given either...
Read More
New Report Counters Claims on the Origin of Gastric Cancer

Mar 11 2020

A new study in Gastroenterology suggests that stem cells from the upper part of the stomach cause changes that can...
Read More
HIPEC With Cisplatin, Mitomycin, and Paclitaxel for Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology

Mar 10 2020

Gastric cancer patients whose disease had spread to the peritoneum received infusions of mitomycin, cisplatin and paclitaxel into the peritoneum...
Read More
More muscle, more protein may improve odds of surviving cancer: study

Mar 09 2020

A review of nearly 150 studies reveals that a diet focused on maintaining muscle mass improves treatment response and survival...
Read More
Risk factors and incidence of gastric cancer after detection of Helicobacter pylori infection: A large cohort study

Feb 24 2020

A study of more than 370,000 veterans with H pylori infections published in Gastroenterology found an increased risk of gastric...
Read More
Immunotherapy with Anti-PD-1 Effective for Patients with Solid Tumors

Feb 20 2020

A review of 13 clinical trials published in JAMA Oncology found that patients with solid tumors, including stomach tumors, had...
Read More
Mindfulness Programming Improves Sleep Quality, Stress Reduction in Survivors and Caregivers

Feb 19 2020

Mindfulness training lowers stress and enhances sleep and resilience in cancer survivors and and caregivers, according to a new study...
Read More
Blood-Based Test Could Help Identify Hard-to-Detect Gastrointestinal Cancers

Feb 13 2020

A blood test that’s being developed to detect cancer at its earliest stages was roughly 90% effective at detecting gastrointestinal...
Read More
Leap Therapeutics Presents Updated Data at the ASCO 2020 Gastrointestinal Cancers Symposium (ASCO GI) Global Meeting

Feb 12 2020

At ASCO GI, Leap Therapeutics announced that in a trial of DKN-01 in patients with advanced gastric cancer, elevated expression...
Read More
Association of Acupuncture and Acupressure With Improved Cancer Pain

Feb 10 2020

A review of clinical trials reveals that acupuncture and acupressure help reduce pain and opioid usage in cancer patients.
BeiGene bags option on Leap cancer drug, requests PD-1 combination trial

Feb 07 2020

BeiGene and Leap Therapeutics have teamed up to study a combination of an anti-DKK1 antibody with the anti-PD-1 antibody tislelizumab...
Read More
BeiGene bags option on Leap cancer drug, requests PD-1 combination trial

Feb 07 2020

BeiGene and Leap Therapeutics have teamed up to study a combination of an anti-DKK1 antibody with the anti-PD-1 antibody tislelizumab...
Read More
Blueprint Medicines Announces FDA Approval of AYVAKIT™ (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor

Feb 05 2020

Blueprint Medicines won FDA approval for Ayvakit (avapritinib), the first treatment for gastrointestinal stromal tumors (GISTs) that targets platelet-derived growth...
Read More
Phase II DESTINY-Gastric01 trial of Enhertu versus chemotherapy met primary endpoint

Feb 04 2020

The new targeted drug Enhertu showed a promising response rate in a trial of patients with HER2-positive gastric cancer.
Light to moderate amount of lifetime alcohol consumption and risk of cancer in Japan

Jan 30 2020

A Japanese study published in the journal Cancer reports that even moderate alcohol consumption raises the risk of cancer and...
Read More
Gritstone posts ‘one of the most potent immunogenic-responses for a neoantigen vaccine’

Jan 27 2020

Two patients with gastroesophageal cancer responded well to Gritstone Oncology’s immune-stimulating treatment in an early trial.
Cancer’s Addiction Could Be A Way to Defeat It

Jan 24 2020

Researchers at the University of Melbourne created gastric cancer “organoids,” tiny replicas of diseased tissue, and used them to discover...
Read More
Many younger patients with stomach cancer have a distinct disease, Mayo research discovers

Jan 21 2020

Mayo Clinic researchers discovered that many people younger than 60 who develop gastric cancer have a genetically distinct form of...
Read More

ADVANCE RESEARCH BY
JOINING THE GASTRIC
CANCER REGISTRY

FIND CLINICAL TRIALS
USING OUR FREE
TRIAL NAVIGATOR

JOIN OUR ONLINE
COMMUNITY OF PATIENTS
AND FAMILY MEMBERS

Support Research for a Cure

Nutrition Videos

Pineapple Smoothie Express!

The Many Functions of Fiber

Jackfruit Barbacoa Tostada

Alternate Grain Pasta

The Power of Probiotics

Roasted Rainbow Carrots

Zesty Cranberries

Fall Pumpkins

What's New

ALX Oncology’s ALX148 Receives Two Fast Track Designations from FDA for the Treatment of Patients with Head and Neck Squamous Cell Carcinoma and Patients with Gastric or Gastroesophageal Junction Adenocarcinoma

Family History of Gastric Cancer and Helicobacter pylori Treatment

Manish Shah, MD, discusses avelumab’s effectiveness based on results from the JAVELIN 100 study

New Report Counters Claims on the Origin of Gastric Cancer

HIPEC With Cisplatin, Mitomycin, and Paclitaxel for Gastric Adenocarcinoma and Associated Carcinomatosis or Positive Cytology

More muscle, more protein may improve odds of surviving cancer: study

Risk factors and incidence of gastric cancer after detection of Helicobacter pylori infection: A large cohort study

Immunotherapy with Anti-PD-1 Effective for Patients with Solid Tumors

Mindfulness Programming Improves Sleep Quality, Stress Reduction in Survivors and Caregivers

Blood-Based Test Could Help Identify Hard-to-Detect Gastrointestinal Cancers

Leap Therapeutics Presents Updated Data at the ASCO 2020 Gastrointestinal Cancers Symposium (ASCO GI) Global Meeting

Association of Acupuncture and Acupressure With Improved Cancer Pain

BeiGene bags option on Leap cancer drug, requests PD-1 combination trial

BeiGene bags option on Leap cancer drug, requests PD-1 combination trial

Blueprint Medicines Announces FDA Approval of AYVAKIT™ (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor

Phase II DESTINY-Gastric01 trial of Enhertu versus chemotherapy met primary endpoint

Light to moderate amount of lifetime alcohol consumption and risk of cancer in Japan

Gritstone posts ‘one of the most potent immunogenic-responses for a neoantigen vaccine’

Cancer’s Addiction Could Be A Way to Defeat It

Many younger patients with stomach cancer have a distinct disease, Mayo research discovers

Monthly Newsletter

Making Strategic Investments Toward a Cure

ADVANCE RESEARCH BY JOINING THE GASTRIC CANCER REGISTRY

FIND CLINICAL TRIALS USING OUR FREE TRIAL NAVIGATOR

JOIN OUR ONLINE COMMUNITY OF PATIENTS AND FAMILY MEMBERS

Support Research for a Cure

Nutrition Videos

What's New

Monthly Newsletter

Making Strategic Investments Toward a Cure

ADVANCE RESEARCH BY
JOINING THE GASTRIC
CANCER REGISTRY

FIND CLINICAL TRIALS
USING OUR FREE
TRIAL NAVIGATOR

JOIN OUR ONLINE
COMMUNITY OF PATIENTS
AND FAMILY MEMBERS